Qian Zhang | Nano-Biomedical Engineering | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Qian Zhang | Nano-Biomedical Engineering | Best Researcher Award

Shanghai Jiao Tong University | China

Assoc. Prof. Dr. Qian Zhang is an accomplished nanomedicine researcher based at Shanghai Jiao Tong University, specializing in the synthesis, surface modification, and biomedical applications of colloidal and magnetic nanomaterials. She earned her Doctor of Science from Philipps-Universität Marburg under Prof. Wolfgang Parak and holds Master’s and Bachelor’s degrees from Sichuan Agriculture University and Qingdao Agriculture University, respectively. Assoc. Prof. Dr. Qian Zhang’s career trajectory includes postdoctoral research, assistant and associate researcher roles at SJTU, and a visiting scientist position at the Weizmann Institute of Science in Israel. Her research focuses on the design of drug delivery systems integrating diagnosis and treatment, interaction of nanomaterials with cancer cells, and physico-chemical characterization of metal-doped magnetic nanomaterials for MRI applications. She has successfully led multiple national and Shanghai-based research projects, including studies on ferromanganese-based nanocarriers for ferroptosis induction and immunotherapy, heat-induced hybrid iron oxide nanocarriers combined with siRNA for early cancer diagnosis, and urine exosomal drug delivery systems for prostate cancer treatment. Assoc. Prof. Dr. Qian Zhang has authored two influential books and 68 publications in high-impact journals, accruing 4,842 citations with an h-index of 29, reflecting her strong scientific influence. Her work demonstrates remarkable innovation, translational relevance, and international collaboration, establishing her as a leading figure in nanomedicine and targeted cancer therapy.

Profile: Scopus

Featured Publications

Zhang, Q. (2026). Element-doped ferrite nanoparticles: From magnetic property tuning to biomedical applications. Coordination Chemistry Reviews, 548, 217151.

Zhao, Y., Zhang, Q., Zhang, A., Pan, S., Cheng, J., Ning, J., … Wang, C. (2025). A novel near-infrared AP-M@AntiACLY detection probe based on SERS to trace detection of serum ACLY for early diagnosis of pediatric sepsis. Sensors and Actuators B: Chemical.

Jin, Y., Huang, J., Tang, Y., Li, Z., Zhang, A., Yang, Z., … Zhang, Q. (2024). Boosting ferroptosis by intervention of redox balance and synergetic with photothermal/photodynamic therapy for suppression of pancreatic cancer. Chemical Engineering Journal, 497.

[Author(s) not fully listed]. (2024). Flower-shaped magnetic fluorescent nanoparticles based lateral flow biosensor for highly sensitive detection of cardiac troponin I. Sensors and Actuators B: Chemical.

[Author(s) not fully listed]. (2024). An ingestible near-infrared fluorescence capsule endoscopy for specific gastrointestinal diagnoses. Biosensors and Bioelectronics.

 

Su Hee Kim | Biomedical device | Best Researcher Award

Published on by Global Academic Awards

Dr. Su Hee Kim | Biomedical device | Best Researcher Award

Dr. Su Hee Kim, Medifab co, Ltd., South Korea

Dr. Su Hee Kim, an accomplished researcher in biomedical engineering, specializes in regenerative medicine, biomaterials, and 3D bioprinting. She serves as the R&D Director at Medifab Co., Ltd., contributing to innovations in tissue engineering and healthcare materials. With a Ph.D. in Nano, Bio, and Information Technology from Korea University, her research has led to numerous patents and publications. Recognized with awards like the Best Research Award in Advanced Healthcare Materials, Dr. Kim’s pioneering work enhances patient-specific medical solutions.

Publication Profile

Scopus

Education 🎓

Dr. Kim earned her Ph.D. in Nano, Bio, and Information Technology from the KU-KIST Graduate School of Converging Science and Technology at Korea University (2016). Prior to that, she completed her M.S. in Biotechnology from Korea University (2010) and a B.S. in Applied Chemistry from Dongduk Women’s University (2008). Her interdisciplinary academic background has equipped her with the expertise to excel in biomaterials research, bioprinting technology, and regenerative medicine.

Experience 💼

Dr. Kim has held leadership and research positions, including her current role as R&D Director at Medifab Co., Ltd. (2021-present). She served as a Senior Researcher and Team Lead at AMRC Korea (2019-2020) and a Research Engineer at AMRC Korea (2017-2019). Additionally, she gained extensive experience as a Post-Doc and Researcher at the Korea Institute of Science and Technology (KIST) from 2007 to 2017. Her career is defined by impactful contributions to biomaterial development and translational medical research.

Awards and Honors 🏆

Dr. Kim’s excellence in research has been acknowledged with several prestigious awards, including the Best Research Award in Advanced Healthcare Materials (2025) and the Best R&D Award from KEIT (2024). She has also received numerous academic honors, such as the Student Oral Presentation Award (2014), SYIS Oral Presentation Award (2014), and multiple scholarships recognizing her outstanding academic achievements during her graduate studies.

Research Focus 🔎

Dr. Kim’s research focuses on regenerative medicine, 3D bioprinting, and biomaterials. Her work involves developing patient-specific grafts using biocompatible scaffolds and hydrogels for tissue regeneration. She has pioneered innovations in vascularized adipose tissue regeneration, cartilage engineering, and self-assembling peptide nanofibers. Her ongoing projects include the commercialization of osteoimmune composite materials and development of ECM bioinks, contributing significantly to advancements in healthcare materials and personalized medicine.

Publication Top Notes

📚 Development of Polycaprolactone Grafts with Improved Physical Properties and Body Stability using a Screw Extrusion-type 3D Bioprinter – International Journal of Bioprinting, 2022

📚 Novel Chitosan Dermal Filler with Enhanced Moldability and Elasticity – Macromolecular Bioscience, 2022

📚 Self-assembling Peptide Gels Promote Angiogenesis and Functional Recovery after Spinal Cord Injury in Rats – Journal of Tissue Engineering, 2022

📚 The Regeneration of Large-Sized and Vascularized Adipose Tissue Using a Tailored Elastic Scaffold and dECM Hydrogels – International Journal of Molecular Sciences, 2021

📚 Detection of Lysyl Oxidase Activity in Tumor Extracellular Matrix Using Peptide-Functionalized Gold Nanoprobes – Cancers, 2021

📚 Study on the Direct Melting Extrusion Metal 3D Printing Using Induction Heating – Journal of the Korean Society of Manufacturing Technology Engineers, 2020

📚 Vascularization of PLGA-Based Bio-Artificial Beds by Hypoxia-Preconditioned Mesenchymal Stem Cells for Subcutaneous Xenogeneic Islet Transplantation – Xenotransplantation, 2018

📚 Skin Regeneration with a Scaffold of Predefined Shape and Bioactive Peptide Hydrogels – Tissue Engineering Part A, 2018 (Cited by: -)

📚 TGF-β3 Encapsulated PLCL Scaffold by a Supercritical CO2-HFIP Co-Solvent System for Cartilage Tissue Engineering – Journal of Controlled Release, 2015

📚 Self-Assembling Peptide Nanofibers Coupled with Neuropeptide Substance P for Bone Tissue Engineering – Tissue Engineering: Part A, 2015

 

Weijie Lai | kidney transplant | Best Researcher Award

Published on by Global Academic Awards

Dr. Weijie Lai | kidney transplant | Best Researcher Award

Weijie Lai at Sun Yat-sen University, China

Dr. Weijie Lai is a dedicated researcher in renal transplantation, specializing in ischemia-free organ transplantation and artificial intelligence applications in transplant medicine. Under the mentorship of Prof. Xiaoshun He, he has contributed significantly to the field by developing predictive models for transplant outcomes and investigating mechanisms of renal allograft rejection. With 7 academic publications, 4 of which are SCI-indexed, his research has been recognized at the national level, including the 2024 Chinese Medical Association’s Electronic Poster Academic Presentation. Dr. Lai’s work focuses on advancing transplant medicine through innovation, clinical database development, and cutting-edge AI methodologies.

Publication Profile

Scopus

Academic Background

Dr. Weijie Lai completed his MD (8-year program) at The First Affiliated Hospital, Sun Yat-sen University, where he was mentored by Prof. Xiaoshun He, a pioneer in ischemia-free organ transplantation. His education provided him with a strong foundation in transplant medicine, immunology, and AI-driven healthcare solutions. Throughout his academic journey, he has engaged in high-impact research, focusing on renal allograft rejection, transplant fibrosis mechanisms, and machine learning applications in medicine. His academic contributions include multiple peer-reviewed publications, national research projects, and clinical database development for renal transplantation.

Professional Experience

Dr. Lai has worked extensively on renal transplantation research, contributing to six ongoing or completed research projects. His experience includes developing AI-driven predictive models for transplant outcomes, reclassification of rejection criteria, and ischemia-free transplantation techniques. He has been actively involved in national grant applications, showcasing his ability to secure research funding. His work has led to peer-reviewed SCI publications, national academic presentations, and the construction of a renal transplant patient database. Despite being early in his career, his innovative approach to transplant medicine places him among the promising researchers in this field.

Awards and Honors

Dr. Lai’s research has received national recognition, with his achievements featured in the 2024 Electronic Poster Academic Presentation Platform of the Chinese Medical Association. His work in ischemia-free transplantation and AI in renal medicine has been widely acknowledged, contributing to the scientific advancements in transplant technology. While he has not yet received formal awards, his contributions in developing predictive models, clinical databases, and machine learning-based classification systems have established his reputation as an emerging leader in transplant research. His continuous efforts in academic publishing and grant applications further highlight his growing impact.

Research Focus

Dr. Lai’s research primarily revolves around renal transplantation, ischemia-free organ transplantation, and AI-driven predictive models. His work explores the mechanisms of renal allograft rejection, fibrosis progression, and innovative approaches to improve transplant success rates. He has developed nomograms and machine learning-based models for outcome prediction, constructed a rule-based rejection classification system, and built a comprehensive renal transplant patient database. His focus on integrating AI into clinical decision-making and improving transplantation methodologies highlights his commitment to revolutionizing the field with data-driven and patient-centric innovations.

Publication Top Notes

Dysregulated lipid metabolism is associated with kidney allograft fibrosis 🧬🔬
Year: 2024 📅 | Cited by: 1 📖 | Journal: Lipids in Health and Disease 🏥

Conclusion

Dr. Weijie Lai is a promising researcher specializing in renal transplantation, ischemia-free organ transplantation, and AI applications in transplant medicine. With 4 SCI-indexed papers and 7 total academic publications, his research has been nationally recognized, including selection for the 2024 Chinese Medical Association’s Electronic Poster Presentation. He has actively participated in national grant applications and contributed to developing predictive AI models and clinical databases for transplant medicine. While his citation impact and leadership roles are still developing, his innovative contributions and specialized expertise make him a strong candidate for the Best Researcher Award, particularly if the award values emerging research excellence.

 

 

Yallappa Rajashekar | Biological Sciences | Outstanding Scientist Award

Published on by Global Academic Awards

Dr.Yallappa Rajashekar | Biological Sciences | Outstanding Scientist Award 

PhD at Institute of Bioresources and Sustainable Development, India

Dr. Yallappa Rajashekar is a distinguished biotechnologist with a Ph.D. in Biotechnology from the University of Mysore (CSIR-CFTRI) in 2011. His academic journey includes an M.Sc. in Zoology (2003) from the University of Mysore and a B.Sc. in Chemistry, Zoology, and Microbiology Honours (1999) from Bangalore University. Recognized for his exemplary contributions, he was honored with the Eminent Young Scientist Award in 2017 by the International Foundation For Environment and Ecology. Additionally, he received the prestigious Prof. T. S. Sadasivan Memorial NABS-Best Research Paper Award in 2016 from the National Academy of Biological Sciences. 🏆🔬

Publication Top Notes :

Scopus 

Orcid 

Google Scholar

Education :

Dr. Yallappa Rajashekar currently holds the esteemed position of Scientist-E, showcasing his expertise and leadership in the scientific realm. He earned his Ph.D. in Biotechnology from the University of Mysore (CSIR-CFTRI) in 2011, marking a significant milestone in his academic journey. Prior to this, he completed his M.Sc. in Zoology at the University of Mysore in 2003 and attained a B.Sc. in Chemistry, Zoology, and Microbiology Honours from Bangalore University in 1999. 🎓 His dedication to advancing knowledge in biotechnology is evident through his progressive educational background and his current role as a distinguished Scientist-E.

Honours/awards :

Dr. Yallappa Rajashekar has garnered a plethora of accolades throughout his illustrious career. Notably, he received the Eminent Young Scientist Award in 2017 and the Young Scientist Award in 2015 from the International Foundation For Environment and Ecology. His outstanding contributions were further acknowledged with the Prof. T. S. Sadasivan Memorial NABS-Best Research Paper Award in 2016 from the National Academy of Biological Sciences. 🏆 Additionally, he was honored with the FSAB and SAB Young Investigator Award in 2012, and in 2011, he earned a Postdoctoral Research Associate title from the Department of Biotechnology (IISc-DBT). His commitment to excellence is exemplified by various prestigious awards, including the SBC Best Poster and Best Oral awards. 🌟

Research Focus :

Dr. Yallappa Rajashekar is a distinguished researcher with a primary focus on the exploration of botanicals as grain protectants. His extensive body of work, spanning various publications, delves into the insecticidal properties of plant extracts, such as those from Decalepis hamiltonii and Lantana camara, for effective grain protection. 🌿 His research also extends to the development of novel natural insecticides and the mode of action of plant-derived compounds. Dr. Rajashekar’s contributions significantly advance the field of entomology, offering sustainable solutions for pest management in stored grains. 🐜🔬

Publication Top Notes :

1.Botanicals as grain protectants

Cited by: 206 | Year of Publication: 2012

2.Traditional methods of food grains preservation and storage in Nigeria and India

Cited by: 111 | Year of Publication: 2019

3.Insecticidal activity of the root extract of Decalepis hamiltonii against stored-product insect pests and its application in grain protection

Cited by: 107 | Year of Publication: 2010

4.A single acute hepatotoxic dose of CCl4 causes oxidative stress in the rat brain

Cited by: 91 | Year of Publication: 2015

5.Leaves of Lantana camara Linn.(Verbenaceae) as a potential insecticide for the management of three species of stored grain insect pests

Cited by: 91 | Year of Publication: 2014

6.Acetylcholinesterase inhibition by biofumigant (Coumaran) from leaves of Lantana camara in stored grain and household insect pests

Cited by: 91 | Year of Publication: 2014

7.Main plant volatiles as stored grain pest management approach: A review

Cited by: 64 | Year of Publication: 2021
8.Enhanced fumigant toxicity of allyl acetate to stored-product beetles in the presence of carbon dioxide

Cited by: 60 | Year of Publication: 2007

9.Isolation and characterization of biofumigant from leaves of Lantana camara for control of stored grain insect pests

Cited by: 52 | Year of Publication: 2013

10.2, 3-Dimethylmaleic anhydride (3, 4-Dimethyl-2, 5-furandione): A plant derived insecticidal molecule from Colocasia esculenta var. esculenta (L.) Schott

Cited by: 47 | Year of Publication: 2016